, Michal Bromberg, Yael Hershkovitz, Hanna Sefty, Zalman Kaufman, Rita Dichtiar, and Lital Keinan-Boker
Figure 2. Adjusted vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 infection in persons 16–59 years of age, by week, September 6, 2021–January 1, 2022 (A), and >60 years of age, by week, August 9, 2021–January 1, 2022 (B), Israel. Adjustments were performed for sex, age, and epidemiologic week. Error bars represent 95% CIs.